Panel backs stricter blood cancer drug label (Reuters)
Reuters – A U. S. advisory panel backed an experimental drug from Seattle Genetics Inc for treating two rare types of blood cancer, but recommended stricter labeling than the company sought.
View full post on Yahoo! News: Health News
Leave a Reply